AAQ1 Stock Overview
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
aap Implantate AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.77 |
52 Week High | €1.58 |
52 Week Low | €0.70 |
Beta | -0.050 |
1 Month Change | 1.32% |
3 Month Change | -3.77% |
1 Year Change | -44.96% |
3 Year Change | -76.43% |
5 Year Change | -92.98% |
Change since IPO | -99.17% |
Recent News & Updates
Recent updates
Investors Give aap Implantate AG (ETR:AAQ1) Shares A 26% Hiding
Jun 15One Analyst Just Shaved Their aap Implantate AG (ETR:AAQ1) Forecasts Dramatically
Aug 20Is aap Implantate (ETR:AAQ1) Weighed On By Its Debt Load?
Apr 04Here's Why aap Implantate (ETR:AAQ1) Can Afford Some Debt
Dec 06Is aap Implantate (ETR:AAQ1) Using Too Much Debt?
Aug 23aap Implantate (ETR:AAQ1) Is Carrying A Fair Bit Of Debt
May 10Shareholder Returns
AAQ1 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -1.2% | 1.9% |
1Y | -45.0% | 4.3% | 7.3% |
Return vs Industry: AAQ1 underperformed the German Medical Equipment industry which returned 4.3% over the past year.
Return vs Market: AAQ1 underperformed the German Market which returned 7.3% over the past year.
Price Volatility
AAQ1 volatility | |
---|---|
AAQ1 Average Weekly Movement | 5.7% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AAQ1 has not had significant price volatility in the past 3 months.
Volatility Over Time: AAQ1's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 111 | Rubino Di Girolamo | https://www.aap.de |
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany, and through a network of distributors internationally.
aap Implantate AG Fundamentals Summary
AAQ1 fundamental statistics | |
---|---|
Market cap | €7.54m |
Earnings (TTM) | -€2.31m |
Revenue (TTM) | €11.96m |
0.6x
P/S Ratio-3.3x
P/E RatioIs AAQ1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AAQ1 income statement (TTM) | |
---|---|
Revenue | €11.96m |
Cost of Revenue | €1.47m |
Gross Profit | €10.49m |
Other Expenses | €12.80m |
Earnings | -€2.31m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.23 |
Gross Margin | 87.72% |
Net Profit Margin | -19.32% |
Debt/Equity Ratio | 8.1% |
How did AAQ1 perform over the long term?
See historical performance and comparison